SkyAI

SkyAI is a biotechnology company that leverages advanced artificial intelligence and machine learning to accelerate the drug discovery and development process. The company's proprietary platform integrates high-throughput biological data with predictive modeling to identify novel therapeutic targets and optimize lead compounds across various disease areas, including oncology and infectious diseases. By utilizing deep learning algorithms, SkyAI aims to reduce the time and cost associated with traditional drug development, ultimately bringing life-saving treatments to patients more efficiently. The company collaborates with pharmaceutical partners and academic institutions to validate its AI-driven insights and advance its internal pipeline of pre-clinical candidates.